Provectus Biopharmaceuticals Cash from Financing (TTM) Insights

Provectus Biopharmaceuticals Inc (PVCT)

0.1985 0.00 (0.00%) USD | OTCM | Apr 26, 15:50

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2000. Upgrade now.

Date	Value
December 31, 2023	2.192M
September 30, 2023	2.464M
June 30, 2023	2.143M
March 31, 2023	1.917M
December 31, 2022	1.368M
September 30, 2022	2.125M
June 30, 2022	2.651M
March 31, 2022	2.625M
December 31, 2021	4.024M
September 30, 2021	2.863M
June 30, 2021	2.790M
March 31, 2021	4.623M
December 31, 2020	3.600M
September 30, 2020	4.825M
June 30, 2020	4.479M
March 31, 2020	3.291M
December 31, 2019	6.754M
September 30, 2019	6.089M
June 30, 2019	6.506M
March 31, 2019	7.077M
December 31, 2018	5.150M
September 30, 2018	6.889M
June 30, 2018	7.269M
March 31, 2018	8.697M
December 31, 2017	9.318M

Date	Value
September 30, 2017	6.950M
June 30, 2017	10.84M
March 31, 2017	7.788M
December 31, 2016	8.924M
September 30, 2016	9.182M
June 30, 2016	3.894M
March 31, 2016	16.87M
December 31, 2015	14.20M
September 30, 2015	17.74M
June 30, 2015	20.86M
March 31, 2015	12.78M
December 31, 2014	15.61M
September 30, 2014	21.45M
June 30, 2014	24.71M
March 31, 2014	22.10M
December 31, 2013	24.37M
September 30, 2013	17.46M
June 30, 2013	11.07M
March 31, 2013	10.86M
December 31, 2012	4.790M
September 30, 2012	2.914M
June 30, 2012	3.107M
March 31, 2012	8.267M
December 31, 2011	16.83M
September 30, 2011	18.01M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.368M

Minimum

Dec 2022

6.754M

Maximum

Dec 2019

3.544M

Average

2.863M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks